Skip to content

Compare the effect of two medicines sthoulyahara choornam and varadi kashaya in the management of obesity

A comparative clinical study on the effect of sthoulyahara choornam and varadi kashaya in the management of sthoulya w.s.r. to obesity

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046110
Enrollment
40
Registered
2022-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

None listed

Sponsors

Dr Jaykrishan Barman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the age group of 20 ââ?¬â?? 70 years with signs & symptoms of sthoulya (obesity) will be selected. 2. Patients having BMI (body mass index) from 25 to less than equals to 35 will be included for the study. 3. Patients of any gender irrespective of socio-economic status. 4. Patient who are ready to sign the informed consent form will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patients, who are suffering from pulmonary diseases, cardiac diseases, hypothyroidism, hypertension, pcod, and other major illness, will not be taken for the study. 2. Patients who are taking medications like - corticosteroid, hormonal therapy, psychiatric medication & protein powder, will not be taken in this study. 3. Patients having BMI greater than 35 kg/m2 will be also excluded.

Design outcomes

Primary

MeasureTime frame
To reduce weight, BMI, waist circumference, hip circumference, waist/hip ratio, skin fold thickness of patientsTimepoint: On day 31

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Jaykrishan Barman

Sri Jayendra Saraswathi Ayurveda College and Hospital

drsrout@gmail.com9444881980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026